Evidence map›Paper›PMID 31441424›Full record

ArticleEmerging infectious diseases2019

Epidemiology of Carbapenemase-Producing Klebsiella pneumoniae in a Hospital, Portugal.

Marta Aires-de-Sousa, José Manuel Ortiz de la Rosa, Maria Luísa Gonçalves, Ana Luísa Pereira, Patrice Nordmann, Laurent Poirel

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Similarity Analysis ofAntibiotics (Basel, Switzerland) · 2023
    Article
  11. ESBL- and Carbapenemase-ProducingMicroorganisms · 2023
    Article
  12. KPC-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  13. Exploring the Antibiotic Resistance Profile of ClinicalAntibiotics (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Epidemiology of Plasmids inAntibiotics (Basel, Switzerland) · 2022
    Article
  17. KPC-3-, GES-5-, and VIM-1-ProducingInternational journal of environmental research and public health · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marta Aires-de-Sousa
José Manuel Ortiz de la Rosa
Maria Luísa Gonçalves
Ana Luísa Pereira
Patrice Nordmann
Laurent Poirel

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to provide updated epidemiologic data on carbapenem-resistant Klebsiella pneumoniae in Portugal by characterizing all isolates (N = 46) recovered during 2013-2018 in a 123-bed hospital in Lisbon. We identified bla

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesDrug Resistance, Multiple, BacterialHospitalsHumansKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsPortugalAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemaseantimicrobial resistancebacterial infectionsBEL-1carbapenemaseGES-5Klebsiella pneumoniaeKPC-3nosocomial infectionsOXA-181Portugal

Identifiers

PMID31441424
PMCPMC6711212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.